Approved in 2015
Grant funding recommendations for medical marijuana research were made by the Medical Marijuana Scientific Advisory Council and approved by the Board of Health on February 18, 2015.
| Project title | Primary investigator | Contact Information | Study Status | Updated grant amount | Results |
|---|---|---|---|---|---|
| Do Adolescents and Young Adults with Inflammatory Bowel Disease Benefit from Use of Marijuana? | Edward J. Hoffenberg, University of Colorado School of Medicine at the Anschutz Medical Campus, Children’s Hospital Colorado | Brittany Murphy | Started October 2015 | $1,191,329*** | Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease. (PubMed website) |
| A Randomized, Double-blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson's Disease | Maureen A. Leehey, Department of Neurology, University of Colorado School of Medicine at the Anschutz Medical Campus | Ying Lui Email: ying.3.lui@ucdenver.edu | Started October 2016 | $1,028,981** | Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. (NIH website) |
| Treating PTSD with Marijuana: Clinical and Functional Outcomes | Marcel O. Bonn-Miller, Dept. of Psychiatry, University of Pennsylvania, and VA National Center for PTSD | Megan Brunstetter | Started October 2015 | $1,181,127*** | Medical Cannabis for PTSD: Current Evidence and Emerging Research in 2015. (MAPS website) |
| Cannabidiol (CBD) and Pediatric Epilepsy | George Sam Wang, Department of Pediatrics, University of Colorado School of Medicine at the Anschutz Medical Campus and Children’s Hospital Colorado | Kendra Kocher Email: Kendra.Kocher@childrenscolorado.org study flyer. (PDF) | Started October 2015 | $576,350*** | |
| Medical Marijuana in the Pediatric Brain Tumor Population (palliative care) | Nicholas Foreman, Dept. of Pediatrics, Pediatric Neuro-oncology, Children’s Hospital Colorado | Christen Volin | Started July 2015 | $1,041,256*** | |
| Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy (pediatric epilepsy) | Kelly Knupp, Dept. of Pediatrics, Children’s Hospital Colorado University of Colorado School of Medicine at the Anschutz Medical Campus | Nana Welnick | Started April 2015 | $631,835** | |
| Placebo-controlled, Triple-Blind, Randomized Crossover Pilot Study of the Safety and Efficacy of Four Potencies of Smoked Marijuana in 76 Veterans with Chronic, Treatment-Resistant Post Traumatic Stress Disorder (PTSD) | Marcel O. Bonn-Miller, University of Pennsylvania and VA National Center for PTSD Note: Grant recipient and study sponsor: MAPS (Multidisciplinary Association for Psychedelic Studies | Berra Yazar-Klosinski Email: berra@maps.org | Started February 2017 | $2,156,000*** | |
| A Double-Blind, Placebo-Controlled Cross Study Comparing the Analgesic Efficacy of Cannabis versus Oxycodone | Emily Lindley, Dept. of Orthopedics, University of Colorado School of Medicine at the Anschutz Medical Campus | Nicole Green Email: MJPainStudy@ucdenver.edu | Started July 2017 | $743,122** | |
| Colorado Cannabis Cohort: Efficacy, Safety, and Usage Patterns of Medical Marijuana for Sleep | Russell Bowler, National Jewish Health | Madeline Morris Email: morrism@njhealth.org | Started August 2015 | $450,000* | |
TOTAL | $9,000,000 |
Notes
*Ninth and most recent grant approved by the Board of Health on 2/18/15 for funding.
**Increased funding amounts were approved by the Board of Health on 2/18/15.
***Final funding amount after contract negotiation with the grantee, which may be less than the maximum funding amount approved by the Board of Health on 12/17/14.